Study to Evaluate Injection Pain and Local Tolerability Following Administration of TV-46046

Study Title
A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous Administration of TV-46046
Teva Identifier
TV46046-WH-10147
ClinicalTrials.gov Identifier
NCT03700658
Study Status
Completed
Trial Condition(s)
Contraception
Interventions
Drug: TV-46046 - 1 | Drug: TV-46046 - 2 | Drug: medroxyprogesterone acetate injectable suspension | Drug: TV-46046 Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age Range
18 Years to 50 Years
Trial Duration
December 14, 2018 - October 2, 2020
Phase
Phase 1

Study Type

Interventional